Overview
Status
Suspended
Registry date
2009-07-14
Share capital
30,000.00 PLN
Registered address
Sarmacka 9/55, 02-972 Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Piotr Mikołaj Zwoliński – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Cezary Adam Morawskiage 61 | 100 | $2,701.24 | 33.3333% |
Jerzy Marceli Zengtelerage 63 | 100 | $2,701.24 | 33.3333% |
Piotr Mikołaj Zwolińskiage 62 | 100 | $2,701.24 | 33.3333% |
Beneficial owners
No beneficial owners recorded for the company Zorix Pharma.
Bank accounts
Was a VAT taxpayer from 2009-07-21 to 2025-11-12.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Mar 2, 2026 | Call to creditors | |
| Feb 18, 2014 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-01-14 | Business suspended | |
| 2025-04-30 | Business resumed | |
| 2014-03-13 | Name change (Zorix Pharma → Zorix Pharma Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2014-01-31 | Liquidation opened | |
| 2011-07-01 | Business suspended |
FAQ
The main business activity of Zorix Pharma focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on July 14, 2009.
The headquarters is located at: Sarmacka 9, 02-972 Warszawa.
The share capital of the company is PLN 30,000 (approx. $8,104).
Last updated: 2026-04-17